Velocity Clinical Research Binghamton — Binghamton, New York

Velocity Clinical Research Binghamton is a clinical research site located in Binghamton, New York, United States 13905.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

Velocity Clinical Research Binghamton has participated in 19 clinical trials with 9 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease, Overweight, Obesity.

Sponsors: Amgen, Merck Sharp & Dohme LLC, Novo Nordisk A/S.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Binghamton

Browse all research sites in New York · View every site in Binghamton

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research Binghamton?

Velocity Clinical Research Binghamton has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research Binghamton conducted?

Velocity Clinical Research Binghamton has 19 clinical trials on record, with 9 currently active. Their work covers Atherosclerotic Cardiovascular Disease, Overweight, Obesity.

Is Velocity Clinical Research Binghamton accredited by Crixeo Clinical Trials?

Velocity Clinical Research Binghamton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research Binghamton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.